Effect of Homologous Blood Components and Heterologous Lysed Red Blood Cells on Dog Renal Dynamics.

1961 ◽  
Vol 108 (1) ◽  
pp. 122-126 ◽  
Author(s):  
W. J. A. Demaria
1952 ◽  
Vol 96 (1) ◽  
pp. 1-15 ◽  
Author(s):  
Erwin Neter ◽  
Lee F. Bertram ◽  
Dorothy A. Zak ◽  
Miriam R. Murdock ◽  
Carl E. Arbesman

A study on hemagglutination and hemolysis by Escherichia coli O111 and O55 (rabbit) antisera and on hemagglutination and hemolysis inhibition by E. coli O111 and O55 antigens revealed the following facts. 1. Red blood cells of man, dog, rabbit, guinea pig, sheep, rat, and chicken adsorb E. coli O111 and O55 antigens and thus become specifically agglutinable by the homologous E. coli antisera. 2. The adsorption of these E. coli antigens is a function of the concentration of the antigen, the time (from 5 minutes to 2 hours) of treatment of the red blood cells with the antigen, and the concentration of the red blood cells used. 3. Red blood cells of man and sheep adsorb simultaneously both antigens, as indicated by the fact that both antisera give agglutination of all red blood cells. Complete agglutination does not occur when a mixture of red blood cells treated separately with the two antigens is added to one or the other of the two antisera. 4. Treatment of red blood cells of man with one of the antigens does not block the adsorption of the second antigen. Human cells treated with either or both antigens are still agglutinated by the homologous blood group (A, B, and Rh)-specific antibodies. 5. In the presence of guinea pig complement, E. coli O111 and O55 antisera produce hemolysis of modified human red blood cells in titers of the same order of magnitude as those giving hemagglutination and bacterial agglutination. The same antisera produce hemolysis of sheep cells treated with the identical antigens in titers exceeding by far those giving agglutination of modified human or sheep red blood cells. 6. Both sediment and supernate of a boiled E. coli suspension are capable of modifying red blood cells for E. coli hemagglutination; in contrast, the supernate obtained from an unboiled suspension and then heated does not modify red blood cells for hemagglutination, although it contains the antigen which can specifically adsorb E. coli antibodies, as shown by means of the hemagglutination and hemolysis inhibition tests. 7. Both the unheated and the boiled suspensions of E. coli O111 and O55 inhibit hemagglutination and hemolysis specifically. 8. Rabbit red blood cells modified by either E. coli O111 or 055 antigens, upon intravenous injection into rabbits, engender specific E. coli antibodies. The significance of the results is discussed.


2019 ◽  
Vol 64 (4) ◽  
pp. 221-224
Author(s):  
A. V. Yovdiy ◽  
E. V. Butina ◽  
E. A. Poponina ◽  
G. A. Zaitseva ◽  
N. V. Minaeva

The correct determination of the blood types of the recipient and the donor is very importante for the choice of blood components for transfusion. As a result of the study, it was established that 18.0% of patients, admitted to the hematology clinic, have difficulties in interpreting of the results of immunohematological tests. Most often, a double population of red blood cells was detected when determining antigens of the Rhesus system (10.9%), auto- (3.9%) and alloantibodies (2.8%). The proposed algorithm for the selection of donor red blood cells in difficult diagnostic cases helps to prevent the development of post-transfusion complications.


Vox Sanguinis ◽  
2012 ◽  
Vol 103 (3) ◽  
pp. 186-193 ◽  
Author(s):  
B. Culibrk ◽  
E. Stone ◽  
E. Levin ◽  
S. Weiss ◽  
K. Serrano ◽  
...  

2020 ◽  
Vol 7 (6) ◽  
pp. 1424
Author(s):  
Vaishnavi Iyengar ◽  
Anjali Parekh ◽  
Sanjay Natu

Background: Audit of transfusion practices in pediatric patients was performed to study indications, clinical profile and whether transfusions were in accordance to guidelines.Methods: Retrospective analysis of all episodes of transfusions from a tertiary care centre was done. The study period was from January 2018 to December 2018.Patients in the age group of 4 months to 12 years were enrolled in the study. The data was reviewed according to the British Committee for Standards in Haematology guidelines for transfusion.Results: During the study period of 12 months,168 units of hemocomponents were transfused to children, 66.07% (111/168) of the total products transfused were packed red cell units, followed by 36 units (21.42%) of fresh frozen plasma and 21 units (12.5%) platelets. Overall usage of blood components was found to be appropriate in 58.33% (98/111). Red blood cells were the most appropriately transfused (64.86 %) (72 units out of 111) blood product as compared to 42.85% of platelets (9/21) and 47.22% of FFP (17/36).Conclusions: Most frequently transfused blood components are red blood cells in pediatrics. Inappropriate transfusion of blood components is hinders the utility of this valuable resource, Thus it becomes necessary to conduct regular audit of blood component transfusion for optimum utilization.


Molecules ◽  
2019 ◽  
Vol 24 (14) ◽  
pp. 2588 ◽  
Author(s):  
Till L. Hennig ◽  
Harald Unterweger ◽  
Stefan Lyer ◽  
Christoph Alexiou ◽  
Iwona Cicha

Magnetic drug targeting utilizes an external magnetic field to target superparamagnetic iron oxide nanoparticles (SPIONs) and their cargo to the diseased vasculature regions. In the arteries, the flow conditions affect the behavior of magnetic particles and the efficacy of their accumulation. In order to estimate the magnetic capture of SPIONs in more physiological-like settings, we previously established an ex vivo model based on human umbilical cord arteries. The artery model was employed in our present studies in order to analyze the effects of the blood components on the efficacy of magnetic targeting, utilizing 2 types of SPIONs with different physicochemical characteristics. In the presence of freshly isolated human plasma or whole blood, a strong increase in iron content measured by AES was observed for both particle types along the artery wall, in parallel with clotting activation due to endogenous thrombin generation in plasma. Subsequent studies therefore utilized SPION suspensions in serum and washed red blood cells (RBCs) at hematocrit 50%. Interestingly, in contrast to cell culture medium suspensions, magnetic accumulation of circulating SPION-3 under the external magnet was achieved in the presence of RBCs. Taken together, our data shows that the presence of blood components affects, but does not prevent, the magnetic accumulation of circulating SPIONs.


Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 2884-2884
Author(s):  
Fabiola G. Rizzatti ◽  
David Stroncek ◽  
Melissa Qazi ◽  
Nathawut Sibmooh ◽  
Barbora Piknova ◽  
...  

Abstract The important role of erythrocytes in nitric oxide (NO) physiology changed the traditional view of the red blood cells (RBC) as only a carrier of oxygen and carbon monoxide. Nitrite is a primary oxidative NO metabolite and is considered a major intravascular storage pool for NO. In the vascular system, erythrocytes are the major storage sites of nitrite, which can be activated to NO by deoxyhemoglobin, but also are responsible for its rapid destruction after reaction with oxyhemoglobin.The purpose of this study was to quantify the nitric oxide metabolites, nitrite and nitrate, in red blood cells (RBCs) stored as packed cells or whole blood and to evaluate their levels with the time of storage. Whole blood, leukoreduced, and non-leukoreduced packed RBCs were obtained from healthy volunteer donors and were stored in polyvinyl chloride (PVC) bags to up to 42 days at 4°C. Sequential aliquots were taken from the bags using a liquid transfer set to maintain sterile conditions. Nitrite and nitrate were measured in the whole blood and in RBC components using reductive gas phase chemiluminescence. Nitrite concentrations decreased during the storage in the three blood components analyzed. The nitrite concentration in RBCs before storage was 202±45 nM, but fell rapidly upon storage. In the leukoreduced RBCs, nitrite levels were 81±36 nM on day 1 and 51±8 nM on day 42. The concentration of nitrate remained stable during blood storage, 30±14 uM on day 1 and 33±5 uM on day 42 of storage. The pH decreased slightly in all three blood components during storage, from pH 6.7±0.05 on day 1 to 6.5±0 on day 42. The blood pO2 before storage was 40.5±1.5 and increased to 251±4 mmHg on day 42, presumably due to the diffusion of oxygen from the room air. In control experiments, PVC bags were filled with normal saline used for medical purposes and stored up to 42 days at 4°C in room air; nitrite concentrations gradually increased while nitrate values remained stable. Similar results were observed for nitrite and nitrate concentrations in the non-leukoreduced RBCs and whole blood. Both cells and saline controls maintained in an argon chamber at 4°C for 42 days showed decreased levels of nitrite when compared to the bags stored in room air under the same temperature. Our results show that nitrite levels fall in hemocomponents during blood bank storage, nitrate remains stable, while pH decreases and pO2 increases. The decrease in nitrite levels could be explained either by its reaction with oxyhemoglobin, resulting in nitrate and methemoglobin, or with deoxyhemoglobin. The diffusion of oxides of nitrogen gases through the PVC bags could in part explain why nitrite levels do not completely disappear in the RBCs stored for transfusion, under standard transfusion medicine conditions. As erythrocytes may contribute to the control of blood flow and oxygen delivery through reduction of nitrite to NO under hypoxic conditions, our findings may provide insight into the vasodynamic effects of blood transfusion. These measurements of NO derivatives may have implication for transfusion therapy, explaining some adverse effects of RBC transfusion and/or optimizing the preservation of stored hemocomponents.


2020 ◽  
Author(s):  
Egarit Noulsri ◽  
Surada Lerdwana ◽  
Duangdao Palasuwan ◽  
Attakorn Palasuwan

Abstract Objective To determine the number of cell-derived microparticles (MPs) in blood products obtained from donors who have thalassemia. Methods Packed red blood cells (PRBCs), plasma, and platelet concentrate (PC) were prepared according to routine procedures. We used flow cytometry to quantitate the concentration of MPs. Results The results of a comparison of MP levels in unprocessed whole blood showed that the concentration of all MPs in the donors without thalassemia trait (n = 255) was higher than in donors with thalassemia trait (n = 70). After processing, increased concentrations of MPs were documented in both groups. Among the blood components, PRBC showed higher platelet-derived MP concentrations in donors with thalassemia than in donors without thalassemia. However, PC showed higher concentrations of total MPs in donors without thalassemia than in donors with that condition. Conclusions Our results suggest little influence of thalassemia-trait status on changes in MP concentrations in blood components.


Antibiotics ◽  
2019 ◽  
Vol 8 (4) ◽  
pp. 221 ◽  
Author(s):  
Vera Sousa ◽  
Ana T. P. C. Gomes ◽  
Américo Freitas ◽  
Maria A. F. Faustino ◽  
Maria G. P. M. S. Neves ◽  
...  

The few approved disinfection techniques for blood derivatives promote damage in the blood components, representing risks for the transfusion receptor. Antimicrobial photodynamic therapy (aPDT) seems to be a promising approach for the photoinactivation of pathogens in blood, but only three photosensitizers (PSs) have been approved, methylene blue (MB) for plasma and riboflavin and amotosalen for plasma and platelets. In this study, the efficiency of the porphyrinic photosensitizer Tri-Py(+)-Me and of the porphyrinic formulation FORM was studied in the photoinactivation of Candida albicans in plasma and in whole blood and the results were compared to the ones obtained with the already approved PS MB. The results show that FORM and Tri-Py(+)-Me are promising PSs to inactivate C. albicans in plasma. Although in whole blood the inactivation rates obtained were higher than the ones obtained with MB, further improvements are required. None of these PSs had promoted hemolysis at the isotonic conditions when hemolysis was evaluated in whole blood and after the addition of treated plasma with these PSs to concentrates of red blood cells.


2014 ◽  
Vol 2014 ◽  
pp. 1-5 ◽  
Author(s):  
Lauren M. McDaniel ◽  
Darrell J. Triulzi ◽  
James Cramer ◽  
Brian S. Zuckerbraun ◽  
Jason L. Sperry ◽  
...  

Widespread, anecdotal belief exists that patients receiving massive transfusion, particularly those for whom a massive transfusion protocol (MTP) is activated, are more likely to receive older red blood cells (RBCs). Retrospective review of blood bank records from calendar year 2011 identified 131 patients emergently issued ≥10 RBC units (emergency release (ER)) prior to obtaining a type and screen. This cohort was subclassified based on whether there was MTP activation. For comparison, 176 identified patients transfused with ≥10 RBC units in a routine fashion over 24 hours represented the nonemergency release (nER) cohort. Though the median age of ER RBCs was 5 days older than nER RBCs (ER 20, nER 15 days, P<0.001), both fell within the third week of storage. Regardless of MTP activation, transfused ER RBCs had the same median age (MTP 20, no-MTP 20 days, P=0.069). In the ER cohort, transition to type-specific blood components increased the median age of transfused RBC units from 17 to 36 days (P<0.001). These data refute the anecdotal belief that MTP activation results in transfusion of older RBCs. However, upon transition to type-specific blood components, the age of RBCs enters a range in which it is hypothesized that there may be a significant effect of storage age on clinical outcomes.


Sign in / Sign up

Export Citation Format

Share Document